FIELD: medicine; psychiatry.
SUBSTANCE: invention can be used for treating postpartum depression. Method involves continuous intravenous infusion of allopregnanolone for 60 hours, wherein the infusion comprises administering in amount of 15 to 70 mcg/kg/h, then, allopregnanolone is administered in amount of 50–100 mcg/kg/h. That is followed by administering allopregnanolone in amount of 15 to 70 mcg/kg/h.
EFFECT: using the invention enables reducing the length of treatment of postpartum depression, reducing the number of side effects of treatment.
6 cl, 10 tbl, 7 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROACTIVE STEROIDS, COMPOSITIONS AND APPLICATIONS THEREOF | 2017 |
|
RU2766155C2 |
| NEUROACTIVE STEROID SOLUTIONS AND METHODS FOR ADMINISTRATION | 2016 |
|
RU2803464C2 |
| ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2667010C2 |
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2824132C2 |
| NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS | 2013 |
|
RU2681835C2 |
| FORMULATIONS OF INTRAVENOUS SOLUTIONS OF POSACONAZOLE STABILISED BY SUBSTITUTED BETA-CYCLODEXTRINE | 2011 |
|
RU2575768C2 |
| NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
| CB1 RECEPTOR ANTAGONISTS | 2012 |
|
RU2593751C2 |
| FORMULATIONS OF 2-IMINOBIOTINE AND USE THEREOF | 2011 |
|
RU2627460C2 |
